Skip to main content
. 2023 Aug 2;620(7973):381–385. doi: 10.1038/s41586-023-06378-w

Fig. 3. Abundance of D. piger and F. prausnitzii in healthy volunteers after administration of D. piger DSM 32187 and F. prausnitzii DSM 32379 for eight weeks.

Fig. 3

a,b, Total faecal counts of D. piger (P = 0.033) (high dose) (a) and F. prausnitzii (b) in metagenomic data before and after administration of the investigational product. c,d, The relative abundance of D. piger DSM 32187 (c) and F. prausnitzii DSM 32186 (d) in metagenomic data before and after administration. n = 13 (placebo), 16 (low dose) and 14 (high dose); **P < 0.01, two-sided Wilcoxon signed-rank test. Data are mean ± s.e.m.